- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/675 - Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
Patent holdings for IPC class A61K 31/675
Total number of patents in this class: 5035
10-year publication summary
|
361
|
380
|
379
|
375
|
502
|
493
|
458
|
441
|
449
|
258
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 2220 |
141 |
| Antecip Bioventures II LLC | 374 |
100 |
| Iovance Biotherapeutics, Inc. | 371 |
73 |
| Merck Sharp & Dohme LLC | 3735 |
45 |
| Immunomedics, Inc. | 239 |
44 |
| The Regents of the University of California | 20720 |
41 |
| The Johns Hopkins University | 5875 |
39 |
| Rigel Pharmaceuticals, Inc. | 507 |
38 |
| Novartis AG | 10263 |
35 |
| Bristol-myers Squibb Company | 4729 |
35 |
| Psilo Scientific Ltd. | 54 |
35 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2999 |
30 |
| Compass Pathfinder Limited | 118 |
27 |
| Ascentawits Pharmaceuticals, Ltd. | 78 |
26 |
| Achillion Pharmaceuticals, Inc. | 157 |
23 |
| Cipla Limited | 476 |
22 |
| Turtle Bear Holdings, LLC | 91 |
22 |
| Hoffmann-La Roche Inc. | 3783 |
21 |
| Centre National de La Recherche Scientifique | 11016 |
21 |
| Pharmacyclics LLC | 241 |
19 |
| Other owners | 4198 |